| scholarly article | Q13442814 |
| P2093 | author name string | Neil S Forbes | |
| Nele Van Dessel | |||
| Jan T Panteli | |||
| Brittany A Forkus | |||
| P2860 | cites work | Protein secretion systems in bacterial-host associations, and their description in the Gene Ontology | Q21263038 |
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| Modeling of the bacterial growth curve | Q24671987 | ||
| Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production | Q24672151 | ||
| High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting | Q27309184 | ||
| Biomarkers in cancer staging, prognosis and treatment selection | Q28278305 | ||
| Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli | Q28744347 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Identification of Staphylococcus aureus α-hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells | Q50003353 | ||
| Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice | Q50004163 | ||
| Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice | Q50072406 | ||
| Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors | Q50102730 | ||
| Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models | Q50110220 | ||
| Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector. | Q50116814 | ||
| Antitumour effects of genetically engineered Salmonella in combination with radiation | Q50118191 | ||
| Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium | Q50120814 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| MR imaging versus PET/CT for evaluation of pancreatic lesions. | Q53093582 | ||
| The underlying mechanisms of type II protein secretion | Q64449375 | ||
| Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions | Q77435859 | ||
| Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens. | Q33719180 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics | Q33792264 | ||
| Imaging angiogenesis and the microenvironment | Q33811205 | ||
| Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus | Q33820285 | ||
| Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors | Q33870710 | ||
| Gram-negative bacterial protein secretion | Q33936210 | ||
| Multiple pathways allow protein secretion across the bacterial outer membrane | Q33954566 | ||
| Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins | Q34301980 | ||
| Optical Properties of Circulating Human Blood in the Wavelength Range 400-2500 nm. | Q34422445 | ||
| Positron emission tomography scanning: current and future applications | Q34511467 | ||
| Expression of the endogenous type II secretion pathway in Escherichia coli leads to chitinase secretion. | Q34685284 | ||
| In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis | Q35053318 | ||
| Minimum antibiotic levels for selecting a resistance plasmid in a gnotobiotic animal model | Q35327706 | ||
| Efficacy of ampicillin therapy in experimental listeriosis in mice with impaired T-cell-mediated immune response | Q35668416 | ||
| Translational genomics: the challenge of developing cancer biomarkers | Q35694362 | ||
| MRI of colorectal cancer liver metastases: comparison of orally administered manganese with intravenously administered gadobenate dimeglumine | Q35718531 | ||
| Quorum sensing in Escherichia coli is signaled by AI-2/LsrR: effects on small RNA and biofilm architecture. | Q35949964 | ||
| Implication of quorum sensing in Salmonella enterica serovar typhimurium virulence: the luxS gene is necessary for expression of genes in pathogenicity island 1. | Q36097281 | ||
| Cancer biomarkers: knowing the present and predicting the future | Q36429381 | ||
| Quorum sensing in Escherichia coli and Salmonella typhimurium. | Q36507025 | ||
| Screening for cancer with PET and PET/CT: potential and limitations. | Q36699798 | ||
| Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli | Q36783792 | ||
| Genetic determinants of cancer metastasis | Q36794312 | ||
| Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane--distinct translocases and mechanisms. | Q36970743 | ||
| Motility is critical for effective distribution and accumulation of bacteria in tumor tissue | Q37115798 | ||
| Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. | Q37424066 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Construction of an inducible cell-communication system that amplifies Salmonella gene expression in tumor tissue | Q39218115 | ||
| Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower | Q39722492 | ||
| Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging | Q39998167 | ||
| Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro | Q40318166 | ||
| Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy | Q40430867 | ||
| Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation | Q40504400 | ||
| Use of PET/CT scanning in cancer patients: technical and practical considerations | Q42564768 | ||
| Photonic detection of bacterial pathogens in living hosts. | Q46008995 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo | Q47992263 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 423-434 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Integrative Biology | Q1524032 |
| P1476 | title | Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker | |
| P478 | volume | 7 |
| Q38806283 | Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects |
| Q39146396 | Carcinogenesis and therapeutics: the microbiota perspective. |
| Q49339110 | Engineering bacteria for diagnostic and therapeutic applications |
| Q57169731 | Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics |
| Q28084076 | Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery |
| Q38693849 | Microfluidics and microbial engineering |
| Q36098726 | Salmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse Model |
| Q26748794 | Strains, Mechanism, and Perspective: Salmonella-Based Cancer Therapy |
| Q53699248 | The role of bacteria in cancer therapy - enemies in the past, but allies at present. |
Search more.